Navigation Links
Sunesis Pharmaceuticals to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Date:10/17/2007

SOUTH SAN FRANCISCO, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a clinical-stage biopharmaceutical company developing novel anticancer therapeutics, today announced that the company will present data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. This year's conference will be held October 22-26, 2007 in San Francisco, California.

Preliminary data from Sunesis' ongoing Phase 2 clinical trial of the company's lead candidate, SNS-595, in platinum-resistant ovarian cancer will be featured in a poster session on Tuesday, October 23, 2007. In addition, the company will present non-clinical data on SNS-595's in vivo activity in combination with standard chemotherapies, and on SNS-032, the company's cyclin-dependent kinase (CDK) inhibitor, currently in development for hematologic malignancies.

Tuesday, October 23, 2007

* Poster Session A - Clinical Trials

Abstract No. A158

A Phase 2 trial of SNS-595 in women with platinum refractory epithelial

ovarian cancer

* Poster Session A -Small Molecule Therapeutic Agents: Kinase Inhibitors

Abstract No. A258

SNS-032 has potent anti-tumor activity in vivo against human leukemia

and multiple myeloma xenografts

Wednesday, October 24, 2007

* Poster Session B - Other Small Molecule Therapeutics

Abstract No. B285

SNS-595 potentiates the in vivo anti-tumor activity of carboplatin,

cisplatin and gemcitabine in solid tumor xenografts

All posters will be presented in the Moscone Convention Center West Exhibit Hall and will also be available following the conference on the Sunesi
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The FBI recently approved t...atories participating in or generating DNA records... Madison, WI USA (PRWEB) -- The FBI re...System for use by laboratories participating in, ...dex System (NDIS). NDIS currently contains more th...
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswi...lyCalottoCapitalInc.,aleadingproviderofadvancedlas...rtilityclinicmarkets,todayreportedoperationalandfi...009. , ,Q32009Highlights,-Revenuewas$1.46million...nwas66.3percentcomparedwith66.1percentinQ3,2008,-N...
(Date:11/24/2009)..., SANDIEGO,Nov.24,2009/PRNewswire-FirstCall/--A...todaythatthecompanyisscheduledtopresentatthePiperJ...09at11:30a.m.EasternTime(8:30a.m.PacificTime)atthe...resident andChiefExecutiveOfficer,isscheduledtopro...elopmentanddiscoveryprograms. ,, Aliveaudiowebc...
(Date:11/24/2009)..., BOZEN,Italy,November24/PRNewswire/--HealthRob...ntventurewithagroupofselected,investors.Thisrecent...meHealthRoboticsCanada,Inc.andwillmarket,install,a...t,whichincludesthe,revolutionaryproductofferingsi....icsCanadaInc.willalsoprovideassistanceonan"asneede...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
...fering Broad Array of Healthcare Products to ...sorders, OTTAWA, April 3, 2008 CSL Behring Canad...es, and Hema-Quebec, have each awarded,the company...c Factor,[Recombinant]), Humate(R) P (Antihemophil... Dried, Pasteurized), Privigen (Immune Globulin In...
...ajority of the Israeli,scientists, in a recent sur...special methods that could "put them into a creati...s desired." Sponsored by the,Jerusalem-based Proje... the,survey surprisingly revealed that, even when ...l sample expressed a medium or high level of,willi...
...nniversary by Ringing The Closing Bell(R) at ... Calif., April 3, 2008 Edwards,Lifesciences Corpo...d,technologies to treat advanced cardiovascular di...tnering with clinicians to develop life-saving,inn...ion and success, and,eight years as an independent...
Other Biology Technology:CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies 2CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies 3CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies 4CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies 5CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies 6CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies 7CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies 8Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3Edwards Lifesciences Celebrates 50 Years of Life-Saving Innovations 2Edwards Lifesciences Celebrates 50 Years of Life-Saving Innovations 3
(Date:11/24/2009)...it has been prescribed by traditional healers in B...and stomach pain to fever and flu. , Now for the ...ve been able to scientifically prove the pain reli...own as Brazilian mint. , Testing this ancient Sou...er Graciela Rocha was able to show that when prepa...
(Date:11/24/2009)...ng new doors to understanding how sounds associate...rine mammal or if they hear it at all. , The sa...hat NASA uses to detect flaws in the space shuttle...entists to peek inside the giant head of a whale. ... replicas of a whale,s hearing anatomy using a bre...
(Date:11/24/2009)...ed and flabby arteries from collapsing have been t...s are no longer needed -- once the arteries are st...octors had no choice but to leave them in place. ,... Department of Biomedical Engineering has develope... drugs where they,re needed, then dissolves. , "...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2A coating for life 2The Dr Oz Show and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houstons Reliant Convention Center on September 57925 1The Dr Oz Show and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houstons Reliant Convention Center on September 57925 2The Dr Oz Show and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houstons Reliant Convention Center on September 57925 3The Dr Oz Show and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houstons Reliant Convention Center on September 57925 4The Dr Oz Show and the National Association of Free Clinics Host One Day Free Public Health Clinic at Houstons Reliant Convention Center on September 57925 5Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 1Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 2Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 3Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 4Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 5Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 6Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 7Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 8Denosumab Demonstrates Superiority Over Zometa 28R 29 in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients 14198 9Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 1Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 2Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 3Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 4Radware Prevents Network Downtime for Carolinas HealthCare System One of the Largest Healthcare Systems in the U S 57918 5
...ivers and streams in the United States,are believe...environmental fate was never thoroughly scrutinize...ost half a century, according to an,analysis condu... School,of Public Health. The chemical, triclocarb... and other cleaning products, but rarely was,monit...
...nome sequence of the parasitic amoeba Entamoeba hi...ease in developing countries, includes an unexpect...s a variety of bacterial-like genes that contribut... which appears in the February 24 issue of Nature,.... It is also the first genome sequence to be publi...
...with aiding efforts to study addicted,smokers, a n...hat have,been implicated in nicotine addiction ,m... such as Alzheimer’s,disease and schizophrenia.,De... Research Center,scientists, the new drug ?Nifroli... specific areas of the brain responsible for,decis...
Other Biology News:Anti-bacterial additive widespread in U.S. waterways 2Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer 2Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer 3Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer 4Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer 5Drug That 'Tags' Decision-making Areas Of The Brain May Aid 2
Goat Anti-HAS1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Donor feline Serum - 500mL from Biomeda Corporation
Goat Anti-NPT1 (M-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
...single head (T2-04 SH) or twin head (T2-04 TH) and...s. Delivering flow up to 7 slpm, this pump works w...rmance, low cost, minimal weight, and compact size...life, and high efficiency. , Provides quiet opera...
Biology Products: